These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. Chamorro A; Vila N; Ascaso C; Blanc R Arch Neurol; 1999 Sep; 56(9):1098-102. PubMed ID: 10488810 [TBL] [Abstract][Full Text] [Related]
25. Heparin dosing. Farnsworth TL S D J Med; 1995 Nov; 48(11):386-7. PubMed ID: 8525352 [No Abstract] [Full Text] [Related]
26. Use of anticoagulants in patients with acute ischemic stroke. Counsell C; Sandercock P Stroke; 1995 Mar; 26(3):522-3. PubMed ID: 7533952 [No Abstract] [Full Text] [Related]
27. Intravenous heparin for acute stroke: what can we learn from the megatrials? Estol CJ Neurology; 2000 Apr; 54(7):1542-3. PubMed ID: 10751280 [No Abstract] [Full Text] [Related]
28. Trials that matter: can patients with venous thromboembolism be treated with fixed-dose subcutaneous unfractionated heparin? Goldhaber SZ; Berkwits M Ann Intern Med; 2006 Dec; 145(12):929-31. PubMed ID: 17179061 [No Abstract] [Full Text] [Related]
29. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis. Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109 [TBL] [Abstract][Full Text] [Related]
31. Interaction of intravenous heparin and organic nitrates in acute ischemic syndromes. Koh KK; Park GS; Song JH; Moon TH; In HH; Kim JJ; Lee HJ; Cho SK; Kim SS Am J Cardiol; 1995 Oct; 76(10):706-9. PubMed ID: 7572630 [TBL] [Abstract][Full Text] [Related]
32. [Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?]. Scharf RE Dtsch Med Wochenschr; 2011 Nov; 136(47):2403. PubMed ID: 22094968 [No Abstract] [Full Text] [Related]
33. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA. Sandercock P; Lindley R; Wardlaw J Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457 [TBL] [Abstract][Full Text] [Related]
34. [Anticoagulants in the treatment of ischemic stroke]. Vilenskiĭ BS Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(1):31-6. PubMed ID: 842222 [TBL] [Abstract][Full Text] [Related]
35. [Strategies for utilization of anticoagulants in pulmonary embolism]. Fartoukh M; Simonneau G Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444 [TBL] [Abstract][Full Text] [Related]
36. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium. Berkowitz SD Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421 [TBL] [Abstract][Full Text] [Related]
38. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Randolph AG; Cook DJ; Gonzales CA; Andrew M Chest; 1998 Jan; 113(1):165-71. PubMed ID: 9440585 [TBL] [Abstract][Full Text] [Related]
39. Low-dose heparin during extracorporeal membrane oxygenation treatment in adults. Yeo HJ; Kim DH; Jeon D; Kim YS; Cho WH Intensive Care Med; 2015 Nov; 41(11):2020-1. PubMed ID: 26271907 [No Abstract] [Full Text] [Related]
40. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk. Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]